Natalia Chaimowitz, M.D., PH.D

NPI: 1306265590
Total Payments
$40,250
2024 Payments
$28,199
Companies
9
Transactions
68

Payment Breakdown by Category

Consulting$16,740 (41.6%)
Other$15,297 (38.0%)
Travel$6,178 (15.4%)
Food & Beverage$1,957 (4.9%)
Education$78.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $16,740 5 41.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,497 7 33.5%
Travel and Lodging $6,178 21 15.4%
Food and Beverage $1,957 31 4.9%
Honoraria $1,800 1 4.5%
Education $78.00 3 0.2%

Top Paying Companies

Company Total Records Latest Year
Grifols USA, LLC $11,715 20 $0 (2024)
Sumitomo Pharma America, Inc. $9,597 11 $0 (2023)
Amgen Inc. $7,664 9 $0 (2024)
Pharming Healthcare, Inc. $5,927 16 $0 (2024)
GENZYME CORPORATION $2,236 3 $0 (2024)
Horizon Therapeutics plc $1,822 2 $0 (2023)
CSL Behring $1,042 3 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $192.23 2 $0 (2023)
SOBI, INC $54.56 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $28,199 45 Grifols USA, LLC ($11,528)
2023 $11,910 20 Sumitomo Pharma America, Inc. ($9,597)
2022 $120.69 2 Takeda Pharmaceuticals U.S.A., Inc. ($94.69)
2019 $20.05 1 CSL Behring ($20.05)

All Payment Transactions

68 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/30/2024 CSL Behring Hizentra (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $900.00 General
Category: Immunology
10/08/2024 Grifols USA, LLC Xembify (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,710.00 General
Category: Immunology and Neurology
10/08/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $120.42 General
Category: Immunology and Neurology
05/14/2024 Grifols USA, LLC Xembify (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,485.00 General
Category: Immunology and Neurology
05/14/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $155.81 General
Category: Immunology and Neurology
04/27/2024 Grifols USA, LLC Xembify (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,145.00 General
Category: Immunology and Neurology
04/27/2024 Grifols USA, LLC Xembify (Biological) Travel and Lodging In-kind items and services $492.75 General
Category: Immunology and Neurology
04/27/2024 Grifols USA, LLC Xembify (Biological) Travel and Lodging In-kind items and services $225.34 General
Category: Immunology and Neurology
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Consulting Fee Cash or cash equivalent $6,300.00 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Travel and Lodging In-kind items and services $464.21 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Travel and Lodging In-kind items and services $350.00 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Food and Beverage In-kind items and services $54.99 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Food and Beverage In-kind items and services $45.01 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Food and Beverage In-kind items and services $24.96 General
Category: Bone/Inflammation/Rare Disease
04/19/2024 Amgen Inc. ACTIMMUNE (Biological) Food and Beverage In-kind items and services $24.96 General
Category: Bone/Inflammation/Rare Disease
04/18/2024 Amgen Inc. ACTIMMUNE (Biological) Travel and Lodging In-kind items and services $260.14 General
Category: Bone/Inflammation/Rare Disease
04/18/2024 Amgen Inc. ACTIMMUNE (Biological) Food and Beverage In-kind items and services $139.59 General
Category: Bone/Inflammation/Rare Disease
04/16/2024 Pharming Healthcare, Inc. JOENJA (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: APDS
04/10/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $22.37 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,145.00 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Travel and Lodging In-kind items and services $848.49 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Travel and Lodging In-kind items and services $134.03 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $110.29 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Travel and Lodging Cash or cash equivalent $54.00 General
Category: Immunology and Neurology
03/21/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage Cash or cash equivalent $23.27 General
Category: Immunology and Neurology

About Natalia Chaimowitz, M.D., PH.D

Natalia Chaimowitz, M.D., PH.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2014. The National Provider Identifier (NPI) number assigned to this provider is 1306265590.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalia Chaimowitz, M.D., PH.D has received a total of $40,250 in payments from pharmaceutical and medical device companies, with $28,199 received in 2024. These payments were reported across 68 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($16,740).

Practice Information

Products in Payments

  • Xembify (Biological) $11,715
  • RETHYMIC (Drug) $9,597
  • ACTIMMUNE (Biological) $7,664
  • JOENJA (Drug) $5,849
  • DUPIXENT (Biological) $2,236
  • ACTIMMUNE (Drug) $1,822
  • Hizentra (Biological) $1,022
  • HYQVIA (Biological) $97.54
  • CINRYZE (Drug) $94.69
  • Gamifant (Drug) $31.95
  • GAMIFANT (Drug) $22.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Fort Worth